The Atherogenic Index of Plasma is a calculated ratio, log(triglycerides/HDL-C), that captures lipid profile atherogenicity in a single value. It correlates strongly with small, dense LDL burden and cardiovascular event rates.
AIP is one of the better single-number summaries of cardiovascular lipid risk, especially when advanced lipoprotein testing isn't available. Values below 0.11 reflect low risk, 0.11-0.21 moderate, and above 0.21 high risk. The index is particularly useful for tracking intervention effects, because it moves more sensitively than any single lipid marker.
Optimal Atherogenic Index of Plasma: -1-0.11 Index.
Typically re-tested every 12 weeks.
A few things worth knowing before the detail:
Atherogenic index of plasma is a calculated lipid marker, defined as the base 10 logarithm of the ratio of triglycerides to HDL cholesterol, both expressed in mmol/L.
Nothing extra is measured in the blood. The calculation takes two routine lipid results and compresses them into a single number that reflects the balance between triglyceride-rich, atherogenic lipoproteins and the protective HDL fraction. Because it is a logarithm, the index can be negative. Values below zero simply mean HDL cholesterol is higher than triglycerides in molar terms.
The mechanism behind the index is lipoprotein remodelling. When triglyceride-rich particles such as VLDL circulate in excess, cholesteryl ester transfer protein shuttles triglycerides into LDL and HDL particles in exchange for cholesteryl esters. Hepatic lipase then strips those triglycerides out, leaving behind LDL particles that are smaller and denser than usual and HDL particles that are cleared from circulation more quickly. Small, dense LDL particles penetrate the arterial wall more readily and are more prone to oxidation, which is why a lipid profile heavy in triglycerides and light in HDL is regarded as more atherogenic than the same total cholesterol spread differently. The index was originally described as a convenient stand-in for that particle size shift, which otherwise needs specialised testing 9.
One technical point matters more than people expect. The index is defined in molar units. If triglycerides and HDL cholesterol are reported in mg/dL, as they commonly are, they must be converted before the logarithm is taken, otherwise the number is not comparable to published thresholds.
It matters because a higher index is associated with atherosclerotic disease and with worse cardiovascular outcomes 2 1.
A systematic review and meta-analysis of patients with coronary artery disease found that a higher index was associated with adverse cardiovascular outcomes 1, and a separate meta-analysis of observational studies reported an association between the index and the presence of coronary artery disease itself 2. Research also suggests the marker carries signal earlier in the disease process 3. One study examined it alongside the triglyceride-glucose index and the monocyte-to-lymphocyte ratio for predicting subclinical coronary artery disease, before symptoms appear 3.
The association is not limited to coronary arteries. A population-based prospective analysis reported a link between the index and incident aortic disease 4. In metabolic conditions, studies indicate the marker tracks with risk as well 5. In people with type 2 diabetes, a higher index was associated with major adverse cardiovascular events 5, and a systematic review and meta-analysis found higher values in people with metabolic syndrome 6.
There is also work on plaque character rather than plaque quantity. In a prospective cohort using optical coherence tomography in patients presenting with ST-elevation myocardial infarction, the index was studied in relation to thin-cap fibroatheroma, a plaque feature associated with instability 7. On the other side of the ledger, research has linked better overall cardiovascular health metrics with a lower index 8, which is part of why the number is treated as a modifiable signal rather than a fixed trait.
All of this is association, not proof of causation, and none of it diagnoses anything in an individual. What it supports is using the index as one input among several when mapping long-term cardiovascular and metabolic risk.
Labs generally regard an index of -1 to 0.21 as the typical reference range, while FitScript's optimal range is narrower at -1 to 0.11.
| Measure | Range (Index) | How it is used |
|---|---|---|
| Typical lab reference range | -1 to 0.21 | The standard range most laboratories report as expected |
| FitScript optimal range | -1 to 0.11 | An optimisation target, narrower than the standard range |
Reference ranges vary by laboratory, assay, age and sex, so read your own report's range rather than assuming a universal cut-off. Optimal ranges are optimisation targets, not diagnostic cut-offs, and a result between the optimal ceiling and the top of the standard range is best described as suboptimal rather than abnormal. No age-specific or sex-specific optimal ranges are published for this marker here, so treating one number as a universal target for every person is the wrong reading. The index is also unitless in the strict sense, since it is a logarithm of a ratio, and is reported simply as an index value.
A high result means the lipid profile is weighted toward triglyceride-rich particles relative to HDL cholesterol, a pattern associated with smaller, denser LDL and with higher cardiovascular risk 9 10.
Symptoms people report. Usually none. Lipid imbalance is silent, and the index itself produces no sensation. People whose results sit high often describe nonspecific things that cluster with insulin resistance, such as weight gain around the midsection, afternoon energy dips after carbohydrate-heavy meals, or difficulty losing fat despite consistent effort. Those experiences are common, nonspecific and cannot confirm anything. Only at very high triglyceride concentrations do distinct signs appear, and those need prompt clinical attention rather than self-interpretation.
Common causes. Elevated triglycerides, reduced HDL cholesterol, or both. Drivers often include insulin resistance and central adiposity, a diet heavy in refined carbohydrate and alcohol, low physical activity, smoking, poor sleep, and underlying conditions such as hypothyroidism, kidney disease or liver disease. Genetics contribute too, particularly in familial patterns of high triglycerides or low HDL. A non-fasting sample inflates triglycerides and therefore the index.
Long-term health impact. Research associates persistently higher values with subclinical and established coronary artery disease 23, with adverse events in people who already have coronary disease 1, and with cardiovascular events in people with type 2 diabetes 5. A single high reading is an observation, not a disease. A repeated high reading, especially alongside raised fasting glucose, blood pressure or waist circumference, is worth discussing with a clinician who can see the whole picture.
A low result means triglycerides are low relative to HDL cholesterol, a pattern generally regarded as favourable and associated in research with better overall cardiovascular health metrics 8.
Symptoms people report. None attributable to the index itself. There is no recognised symptom set for a low value, and the number is not low in the way a vitamin or hormone can be deficient. It is a ratio, and the lower end simply reflects a favourable lipid distribution.
Common causes. High habitual aerobic activity, lower body fat and good insulin sensitivity, a diet lower in refined carbohydrate and alcohol, and favourable genetics for HDL metabolism. Some medications and supplements that lower triglycerides, including omega-3 preparations and fibrates, shift the ratio downward, and a licensed provider evaluates whether any such option is appropriate for a given person. Occasionally a very low triglyceride value reflects something that deserves attention rather than celebration, such as malabsorption, undernutrition or an overactive thyroid, which is why context matters.
Long-term health impact. A low value is reassuring about one specific axis of risk and nothing more. It says little about LDL particle number, apolipoprotein B, lipoprotein(a), blood pressure, glucose regulation or inflammation. It is entirely possible to have a comfortably low index alongside an elevated LDL cholesterol that still warrants discussion. Treating a single favourable ratio as an all-clear is the most common misreading of this marker.
The index moves with both real physiology and with how the sample was taken, so testing conditions matter as much as habits.
The index is derived from a standard lipid panel, so it is calculated from the triglyceride and HDL cholesterol results rather than ordered separately.
FitScript is a labs-first membership built around 150+ biomarkers tested per year, which means lipid markers are measured repeatedly rather than once, and the index can be tracked as a trend line instead of a snapshot. That repetition is the point. A single value sits inside normal biological variation, while a direction of travel across several draws under similar fasting conditions is far more informative.
Results are interpreted by Atlas, the AI health advisor, which reads the index in context with the rest of the lipid panel, glucose and insulin markers, inflammatory markers and body composition, then writes your FitScript, the personalised output generated from your own biology. Where a result sits outside the optimal range, the output frames it as an observation to review, what it may reflect, and what is worth raising with a clinician. Where a prescription therapy might be relevant, a licensed provider evaluates whether it is appropriate after reviewing the member, and the interpretation itself produces no treatment guidance. A result that needs prompt care is flagged as worth discussing with a clinician promptly, never ignored.
The index is a summary of two numbers, so it is most useful read next to its own components and next to the broader cholesterol picture it does not capture.
Start with the two inputs, Triglycerides and HDL Cholesterol, since a change in the index always traces back to one of them, and compare it with the simpler Triglyceride/HDL Ratio, which carries similar information without the logarithm. Because this marker says nothing about cholesterol burden, pair it with Cholesterol - Total, LDL Cholesterol and the Cholesterol / HDL Ratio to see both the quality and the quantity of circulating lipoproteins, and review the whole set together on a Heart Health panel rather than one marker at a time.
Atherogenic index of plasma turns two familiar lipid results into one number that reflects how atherogenic a profile looks. Research associates higher values with coronary disease, with events in people who already have coronary disease or type 2 diabetes, and with aortic disease, while lower values track with better cardiovascular health metrics 2 1 5 4 8. It is sensitive to fasting status, alcohol, medications and unit conversion, so conditions and consistency matter. It does not diagnose anything, and it does not replace LDL cholesterol or apolipoprotein B as a measure of lipoprotein burden. This article is educational and is not medical advice. Discuss your results, and any treatment option, with a clinician or licensed provider who can review your full history.
It is the base 10 logarithm of triglycerides divided by HDL cholesterol, with both values in mmol/L. If your report uses mg/dL, the values must be converted to molar units first, otherwise the result will not match published thresholds.
Laboratories typically report -1 to 0.21 as the standard reference range, and FitScript's optimal range is narrower at -1 to 0.11. Ranges vary by laboratory, age and sex, and an optimal range is an optimisation target rather than a diagnostic cut-off.
Yes. Because it is a logarithm of a ratio, any result where triglycerides are lower than HDL cholesterol in molar terms produces a negative number. A negative value is normal and generally regarded as favourable.
Triglycerides rise after eating, which raises the index, so a fasted morning draw is usually preferred for comparability. Follow the instructions given with your lab requisition, and keep the conditions consistent between tests so the trend means something.
No. A high value is an observation, not a diagnosis. Higher values are associated with coronary artery disease and with cardiovascular events, but no single lipid number can confirm disease in an individual. A repeated high result is worth discussing with a clinician.
It is not a replacement. The index reflects the balance between triglyceride-rich particles and HDL, which relates to LDL particle size, while LDL cholesterol and apolipoprotein B reflect lipoprotein burden. The two answer different questions and are most useful read together.
Triglycerides respond to diet, alcohol and activity within days to weeks, so the index can move faster than many lipid markers. HDL tends to shift more slowly. Because short-term variation is real, a trend across several tests is more informative than any single result.
Triglycerides and HDL cholesterol first, since the index is derived from them, then total cholesterol, LDL cholesterol and the cholesterol to HDL ratio for lipoprotein burden. Glucose, insulin and inflammatory markers add metabolic context. A clinician or licensed provider can interpret the set as a whole.